Investors pour over $30bn into longevity biotech as report predicts longevity drugs from 2035

Barchart · 2d ago

Longevity Biotech Report forecasts a $617bn market by 2045.

LONDON, Sept. 16, 2026 /PRNewswire/ -- Global investment in longevity biotech reached a record $18.4bn in 2025, up from $4.7bn in 2024, with $12.1bn already invested in 2026, according to a new report from Longevity.Technology.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.